Embryonic Morphogen Nodal Promotes Breast Cancer Growth and Progression

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Quail, Daniela F ^a   Zhang, Guihua ^a   Walsh, Logan A ^b   Siegers, Gabrielle M ^a   Dieters Castator, Dylan Z ^a   Findlay, Scott D ^a   Broughton, Heather ^c   Putman, David M ^c   Hess, David A ^c   Postovit, Lynne Marie ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c ROBARTS RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN; ACTIVIN LIKE KINASE 4; ACTIVIN LIKE KINASE 7; CASPASE 9; CRIPTO 1 PROTEIN; HISTONE H3; KI 67 ANTIGEN; MEMBRANE PROTEIN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN NODAL; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BAX GENE; BCL2 GENE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER CELL; CANCER GROWTH; CANCER INHIBITION; CELL EXPANSION; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION; HISTONE PHOSPHORYLATION; HUMAN; HUMAN CELL; IN VITRO STUDY; METASTASIS; MICROMETASTASIS; MOUSE; NONHUMAN; PROTEIN CLEAVAGE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ACTIVIN RECEPTORS, TYPE I; ANIMALS; APOPTOSIS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION; GENE KNOCKDOWN TECHNIQUES; GPI-LINKED PROTEINS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LUNG NEOPLASMS; MICE; MICE, INBRED NOD; MICE, NUDE; MICE, SCID; NEOPLASM MICROMETASTASIS; NEOPLASM PROTEINS; NEOPLASM TRANSPLANTATION; NODAL PROTEIN; RNA, SMALL INTERFERING; TUMOR BURDEN;

MUS;

EID: 84868688889     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0048237     Document Type: Article

References (38)

1. Hanahan D, Weinberg RA, (2011) Hallmarks of cancer: the next generation. Cell 144: 646-674.
2. Hanahan D, Weinberg RA, (2000) The hallmarks of cancer. Cell 100: 57-70.
3. Yerushalmi R, Woods R, Ravdin PM, Hayes MM, Gelmon KA, (2010) Ki67 in breast cancer: prognostic and predictive potential. Lancet Oncol 11: 174-183.
4. Urruticoechea A, Smith IE, Dowsett M, (2005) Proliferation marker Ki-67 in early breast cancer. J Clin Oncol 23: 7212-7220.
5. Dowsett M, Nielsen TO, A'Hern R, Bartlett J, Coombes RC, et al. (2011) Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group. J Natl Cancer Inst 103: 1656-1664.
6. Vermeulen PB, Gasparini G, Fox SB, Toi M, Martin L, et al. (1996) Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluation. Eur J Cancer 32A: 2474-2484.
7. Lawrence MG, Margaryan NV, Loessner D, Collins A, Kerr KM, et al. (2011) Reactivation of embryonic nodal signaling is associated with tumor progression and promotes the growth of prostate cancer cells. Prostate 71: 1198-1209.
8. Lee CC, Jan HJ, Lai JH, Ma HI, Hueng DY, et al. (2010) Nodal promotes growth and invasion in human gliomas. Oncogene 29: 3110-3123.
9. Topczewska JM, Postovit LM, Margaryan NV, Sam A, Hess AR, et al. (2006) Embryonic and tumorigenic pathways converge via Nodal signaling: role in melanoma aggressiveness. Nat Med 12: 925-932.
10. Postovit LM, Seftor EA, Seftor RE, Hendrix MJ, (2007) Targeting Nodal in malignant melanoma cells. Expert Opin Ther Targets 11: 497-505.
11. Postovit LM, Margaryan NV, Seftor EA, Kirschmann DA, Lipavsky A, et al. (2008) Human embryonic stem cell microenvironment suppresses the tumorigenic phenotype of aggressive cancer cells. Proc Natl Acad Sci U S A 105: 4329-4334.
12. Strizzi L, Postovit LM, Margaryan NV, Lipavsky A, Gadiot J, et al. (2009) Nodal as a biomarker for melanoma progression and a new therapeutic target for clinical intervention. Expert Rev Dermatol 4: 67-78.
13. Papageorgiou I, Nicholls PK, Wang F, Lackmann M, Makanji Y, et al. (2009) Expression of nodal signalling components in cycling human endometrium and in endometrial cancer. Reprod Biol Endocrinol 7: 122.
14. Lonardo E, Hermann PC, Mueller MT, Huber S, Balic A, et al. (2011) Nodal/Activin signaling drives self-renewal and tumorigenicity of pancreatic cancer stem cells and provides a target for combined drug therapy. Cell Stem Cell 9: 433-446.
15. Cavallari C, Fonsato V, Herrera MB, Bruno S, Tetta C, et al. (2012) Role of Lefty in the anti tumor activity of human adult liver stem cells. Oncogene: onc2012114 [pii];10.1038/onc.2012.114 [doi].
16. Kenney NJ, Adkins HB, Sanicola M, (2004) Nodal and Cripto-1: embryonic pattern formation genes involved in mammary gland development and tumorigenesis. J Mammary Gland Biol Neoplasia 9: 133-144.
17. Bianco C, Adkins HB, Wechselberger C, Seno M, Normanno N, et al. (2002) Cripto-1 activates nodal- and ALK4-dependent and-independent signaling pathways in mammary epithelial Cells. Mol Cell Biol 22: 2586-2597.
18. Strizzi L, Hardy KM, Margaryan NV, Hillman DW, Seftor EA, et al. (2012) Potential for the embryonic morphogen Nodal as a prognostic and predictive biomarker in breast cancer. Breast Cancer Res 14: R75.
19. Strizzi L, Postovit LM, Margaryan NV, Seftor EA, Abbott DE, et al. (2008) Emerging roles of nodal and Cripto-1: from embryogenesis to breast cancer progression. Breast Dis 29: 91-103.
20. Kao J, Salari K, Bocanegra M, Choi YL, Girard L, et al. (2009) Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discovery. PLoS One 4: e6146.
21. Quail DF, Walsh LA, Zhang G, Findlay SD, Moreno J, et al. (2012) Embryonic Protein Nodal Promotes Breast Cancer Vascularization. Cancer Research 72: 3851-3863.
22. Inman GJ, Nicolas FJ, Callahan JF, Harling JD, Gaster LM, et al. (2002) SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7. Mol Pharmacol 62: 65-74.
23. Le Good JA, Joubin K, Giraldez AJ, Ben-Haim N, Beck S, et al. (2005) Nodal stability determines signaling range. Curr Biol 15: 31-36.
24. Quail DF, Taylor MJ, Walsh LA, Dieters-Castator D, Das P, et al. (2011) Low oxygen levels induce the expression of the embryonic morphogen Nodal. Mol Biol Cell 22: 4809-4821.
25. Hess DA, Craft TP, Wirthlin L, Hohm S, Zhou P, et al. (2008) Widespread nonhematopoietic tissue distribution by transplanted human progenitor cells with high aldehyde dehydrogenase activity. Stem Cells 26: 611-620.
26. Schier AF, (2009) Nodal morphogens. Cold Spring Harb Perspect Biol 1: a003459.
27. Vo BT, Khan SA, (2011) Expression of nodal and nodal receptors in prostate stem cells and prostate cancer cells: autocrine effects on cell proliferation and migration. Prostate 71: 1084-1096.
28. Hardy KM, Kirschmann DA, Seftor EA, Margaryan NV, Postovit LM, et al. (2010) Regulation of the embryonic morphogen Nodal by Notch4 facilitates manifestation of the aggressive melanoma phenotype. Cancer Res 70: 10340-10350.
29. Xu G, Zhong Y, Munir S, Yang BB, Tsang BK, et al. (2004) Nodal induces apoptosis and inhibits proliferation in human epithelial ovarian cancer cells via activin receptor-like kinase 7. J Clin Endocrinol Metab 89: 5523-5534.
30. Zhong Y, Xu G, Ye G, Lee D, Modica-Amore J, et al. (2009) Nodal and activin receptor-like kinase 7 induce apoptosis in human breast cancer cell lines: Role of caspase 3. Int J Physiol Pathophysiol Pharmacol 1: 83-96.
31. Bachman KE, Park BH, (2005) Duel nature of TGF-beta signaling: tumor suppressor vs. tumor promoter. Curr Opin Oncol 17: 49-54.
32. Pardali K, Moustakas A, (2007) Actions of TGF-beta as tumor suppressor and pro-metastatic factor in human cancer. Biochim Biophys Acta 1775: 21-62.
33. Luzzi KJ, MacDonald IC, Schmidt EE, Kerkvliet N, Morris VL, et al. (1998) Am J Pathol. 153: 865-873.
34. Hunter KW, Crawford NP, Alsarraj J, (2008) Mechanisms of metastasis. Breast Cancer Res 10 (Suppl 1): S2.
35. Aguirre-Ghiso JA, (2007) Models, mechanisms and clinical evidence for cancer dormancy. Nat Rev Cancer 7: 834-846.
36. Holmgren L, O'Reilly MS, Folkman J, (1995) Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat Med 1: 149-153.
37. Al-Hajj M, Wicha MS, ito-Hernandez A, Morrison SJ, Clarke MF, (2003) Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A 100: 3983-3988.
38. Croker AK, Goodale D, Chu J, Postenka C, Hedley BD, et al. (2009) High aldehyde dehydrogenase and expression of cancer stem cell markers selects for breast cancer cells with enhanced malignant and metastatic ability. J Cell Mol Med 13: 2236-2252.